Screening for Hypercalcemia in Subcutaneous Fat Necrosis
All infants with subcutaneous fat necrosis should have an initial ionized calcium level measured at diagnosis, followed by serial monitoring every 1-2 weeks for the first 3 months of life, as hypercalcemia occurs in 100% of monitored infants and can lead to life-threatening complications including nephrocalcinosis and acute kidney injury 1.
Initial Assessment
When SCFN is suspected or diagnosed:
- Obtain baseline ionized calcium immediately - this is the most sensitive marker 1
- Measure serum calcium, phosphorus, PTH, 25-hydroxyvitamin D, and 1,25-dihydroxyvitamin D
- Obtain baseline renal function (BUN, creatinine)
- Perform renal ultrasound to evaluate for nephrocalcinosis 1, 2
Monitoring Schedule
The evidence strongly supports structured surveillance based on timing of hypercalcemia development:
First 30 days after skin lesion onset:
- Check ionized calcium every 1-2 weeks
- 77% of hypercalcemia cases are detected within this window 3
- 86% of patients demonstrate peak calcium levels during this period 1
Days 30-60:
- Continue monitoring every 2 weeks
- 95% of hypercalcemia develops by day 60 3
Days 60-90:
- Monitor every 2-3 weeks
- Only 4% develop hypercalcemia after day 70 3
- No patients in the largest series developed hypercalcemia after 3 months 1
After 3 months:
- Monitoring can be discontinued if hypercalcemia has not occurred 1
Risk Stratification by Calcium Level
Ionized calcium <1.5 mmol/L (asymptomatic):
- Continue outpatient monitoring per schedule above
- Low likelihood of complications 1
- No specific interventions needed beyond surveillance
Ionized calcium 1.5-1.6 mmol/L:
- 62% of infants fall in this range 1
- Increase monitoring frequency to weekly
- Implement dietary calcium restriction
- Consider low-calcium formula
Ionized calcium >1.6 mmol/L or symptomatic at any level:
- Immediate endocrinology or nephrology consultation 1
- Consider hospitalization 1
- Repeat renal ultrasound to assess for nephrocalcinosis
- Initiate treatment with hyperhydration, furosemide, and consider corticosteroids or calcitonin 4, 5
Clinical Symptoms Requiring Urgent Evaluation
Monitor closely for signs of hypercalcemia:
- Poor feeding, anorexia, or failure to thrive 1, 6
- Vomiting 1, 6
- Irritability or lethargy 6
- Constipation 6
- Polyuria and polydipsia 4
Critical Pitfalls to Avoid
Do not rely on a single normal calcium level - 91% of infants who had calcium drawn developed hypercalcemia, and most cases manifest weeks after skin lesions appear 1. The median onset is day 28, but the range extends to day 210 5.
Do not stop monitoring at skin lesion resolution - hypercalcemia can develop or persist well after skin findings resolve, with 76% requiring 4 weeks for calcium normalization after detection 3.
Do not assume asymptomatic means safe - 52% of hypercalcemia cases are asymptomatic 5, yet complications including nephrocalcinosis and acute kidney injury still occur 1, 2.
High-Risk Features
Higher birthweight significantly predicts hypercalcemia development (p=0.022) 3. Full-term infants trend toward higher risk compared to preterm (p=0.054) 3. History of therapeutic hypothermia, birth asphyxia, or perinatal complications increases SCFN risk 5, 2.
Duration of Hypercalcemia
Most cases (76%) resolve within 4 weeks of detection 3, but persistent elevation beyond 6 months warrants aggressive management with coordinated subspecialty care 1. Two deaths have been reported in the literature among 15 cases, emphasizing the potential severity 6.